Skip to main content

Advertisement

Log in

UK academic drug discovery

  • From the Analyst's Couch
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Drug discovery research in UK academic groups compared with US academic groups and the pharmaceutical industry.
Figure 2: Funding sources for academic drug discovery.

References

  1. Frye, S. et al. US academic drug discovery. Nature Rev. Drug Discov. 10, 409–410 (2011).

    CAS  Google Scholar 

  2. Rathi, A. Removing boundaries. RSC News 10–11 (Jan 2013).

Download references

Acknowledgements

The authors thank the survey participants and acknowledge the help received from Thomson Reuters Life Sciences to run and analyse the survey, and in supplying comparative industry data.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cathy Tralau-Stewart.

Ethics declarations

Competing interests

C.T.-S. and C.L. act as consultants to academia, biotechnology companies and pharmaceutical companies.

Supplementary information

Supplementary information S1 (box)

Academic Drug Discovery Study (PDF 742 kb)

Supplementary information S2 (box)

Survey methods and supplementary data (PDF 2798 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tralau-Stewart, C., Low, C. & Marlin, N. UK academic drug discovery. Nat Rev Drug Discov 13, 15–16 (2014). https://doi.org/10.1038/nrd4200

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd4200

  • Springer Nature Limited

This article is cited by

Navigation